Author

JK Erban

Lack of benefit from semi‐annual screening for cancer of the lung: Follow‐up report of a randomized controlled trial on a population of high‐risk males in czechoslovakia

1990 · A. Kubik, D. M. Parkin, et al. · International Journal of Cancer · 258

NSABP B-30: definitive analysis of patient outcome from a randomized trial evaluating different schedules and combinations of adjuvant therapy containing doxorubicin, docetaxel and cyclophosphamide in women with operable, node-positive breast cancer.

2009 · SM Swain, J Jeong, et al. · Cancer Research · 34

Dose-dense neoadjuvant treatment of women with breast cancer utilizing docetaxel, vinorelbine and trastuzumab with growth factor support

2005 · M. Jahanzeb, A. Brufsky, et al. · Journal of Clinical Oncology · 28

Abstract P2-16-23: The ENCHANT-1 trial (NCT01677455): An open label multicenter phase 2 proof of concept study evaluating first line ganetespib monotherapy in women with metastatic HER2 positive or triple negative breast cancer (TNBC)

2013 · A Awada, N Spector, et al. · Cancer Research · 4

NSABP B-30: definitive analysis of quality of life (QOL) and menstrual history (MH) outcomes from a randomized trial evaluating different schedules and combinations of adjuvant therapy containing doxorubicin, docetaxel and cyclophosphamide in women with operable, node-positive breast cancer.

2009 · PA Ganz, SR Land, et al. · Cancer Research · 4

Works count: 5

Citation count: 328

H-index: 4

I10-index: 3